BioNTech (BNTX) News Today $120.01 +2.13 (+1.81%) Closing price 04:00 PM EasternExtended Trading$122.39 +2.38 (+1.98%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Flossbach Von Storch SE Increases Holdings in BioNTech SE (NASDAQ:BNTX)Flossbach Von Storch SE lifted its position in BioNTech SE (NASDAQ:BNTX - Free Report) by 1.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,406,843 shares of the company's stock after purchasing an additional 47,236 shares during the period. BioFebruary 21 at 7:09 AM | marketbeat.comC2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New Investment in BioNTech SE (NASDAQ:BNTX)C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,810 shares ofFebruary 19 at 5:31 AM | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. cut its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,220,581 shares of the company's stocFebruary 17, 2025 | marketbeat.comVontobel Holding Ltd. Has $2.44 Million Position in BioNTech SE (NASDAQ:BNTX)Vontobel Holding Ltd. lifted its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 24.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,385 shares of the company's stock after buying an additionalFebruary 17, 2025 | marketbeat.comVan ECK Associates Corp Boosts Stock Position in BioNTech SE (NASDAQ:BNTX)Van ECK Associates Corp increased its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 25.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 118,418 shares of the company's stock after purchasing an additional 23,733 sharFebruary 16, 2025 | marketbeat.comC2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Buys New Holdings in BioNTech SE (NASDAQ:BNTX)C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,810 sharFebruary 14, 2025 | marketbeat.comSenate votes to confirm Robert Kennedy as head of HHSFebruary 14, 2025 | markets.businessinsider.comBioNTech SE (NASDAQ:BNTX) Receives $142.72 Average Target Price from AnalystsFebruary 13, 2025 | americanbankingnews.comBioNTech SE (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of BioNTech SE (NASDAQ:BNTX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seventeen research firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, thirteen have assigned aFebruary 10, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Purchased by abrdn plcabrdn plc raised its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 70.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 385,668 shares of the company's stock after purchasiFebruary 6, 2025 | marketbeat.comRFK Jr. HHS nomination advances out of Senate Finance CommitteeFebruary 5, 2025 | seekingalpha.comBioNTech price target lowered to $147 from $150 at BofAFebruary 5, 2025 | markets.businessinsider.comModerna and BioNTech shares fall after Senate committee vote RFK Jr.February 4, 2025 | au.investing.comModerna and BioNTech shares fall after Senate committee vote on RFK Jr.February 4, 2025 | msn.comModerna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s NominationFebruary 4, 2025 | msn.comVaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretaryFebruary 4, 2025 | cnbc.comVaccine, packaged food stocks fall as Kennedy moves closer to health secretary jobFebruary 4, 2025 | reuters.comBioNTech fair value analysis yields 51% return in six monthsFebruary 4, 2025 | msn.comBank of America Securities Reaffirms Their Buy Rating on BioNTech SE (BNTX)February 4, 2025 | markets.businessinsider.comBioNTech SE: BioNTech Completes Acquisition of BiotheusFebruary 4, 2025 | finanznachrichten.deBioNTech SE Expands Oncology Strategy with Acquisition of BiotheusFebruary 3, 2025 | gurufocus.comBioNTech Completes Acquisition of BiotheusFebruary 3, 2025 | globenewswire.comBioNTech SE (NASDAQ:BNTX) Short Interest UpdateBioNTech SE (NASDAQ:BNTX - Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 2,550,000 shares, an increase of 9.4% from the December 31st total of 2,330,000 shares. Based on an average daily trading volume, of 806,600 shares, the short-interest ratio is currently 3.2 days.February 2, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Sells 13,644 Shares of BioNTech SE (NASDAQ:BNTX)Robeco Institutional Asset Management B.V. decreased its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 11.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 101,408 shares of the company's stock after sFebruary 2, 2025 | marketbeat.comBioNTech's SWOT analysis: oncology pipeline, cash boost stock outlookJanuary 30, 2025 | msn.comSivik Global Healthcare LLC Acquires Shares of 15,000 BioNTech SE (NASDAQ:BNTX)Sivik Global Healthcare LLC bought a new position in BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 15,000 shares of the company's stock, valued at approximately $1,709,000. A number ofJanuary 30, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Baader Bank AktiengesellschaftBaader Bank Aktiengesellschaft decreased its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 2.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 140,400 shares of the company's stock aftJanuary 30, 2025 | marketbeat.comUnion Bancaire Privee UBP SA Makes New Investment in BioNTech SE (NASDAQ:BNTX)Union Bancaire Privee UBP SA purchased a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,500 shares of the company's stock, valued at approximatJanuary 29, 2025 | marketbeat.comModerna stock rises following RFK Jr's commentsJanuary 28, 2025 | msn.comSlow Capital Inc. Decreases Holdings in BioNTech SE (NASDAQ:BNTX)Slow Capital Inc. lowered its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,727 shares of the company's stock after selling 2,January 28, 2025 | marketbeat.comMorgan Stanley Sticks to Their Buy Rating for BioNTech SE (BNTX)January 28, 2025 | markets.businessinsider.comBioNTech SE (BNTX) Receives a Hold from J.P. MorganJanuary 28, 2025 | markets.businessinsider.comSG Americas Securities LLC Buys 33,375 Shares of BioNTech SE (NASDAQ:BNTX)SG Americas Securities LLC raised its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 412.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,470 shares of the company's stock after buying anJanuary 25, 2025 | marketbeat.comBioNTech SE: Lackluster Financials And Uncertainties In Product Pipeline-HoldJanuary 23, 2025 | seekingalpha.com6,000 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Mirabaud & Cie SAMirabaud & Cie SA purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 6,000 shares of the company's stock, valued at approximately $684,000. Other large investors alsoJanuary 22, 2025 | marketbeat.com3 Dirt-Cheap Stocks to Buy in a Market That's Priced for PerfectionJanuary 22, 2025 | fool.comBerenberg Bank Remains a Buy on BioNTech SE (BNTX)January 21, 2025 | markets.businessinsider.comBioNTech SE (NASDAQ:BNTX) Sees Large Increase in Short InterestBioNTech SE (NASDAQ:BNTX - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 2,550,000 shares, a growth of 9.4% from the December 15th total of 2,330,000 shares. Based on an average daily volume of 806,600 shares, the short-interest ratio is presently 3.2 days.January 18, 2025 | marketbeat.comRetireful LLC Makes New $260,000 Investment in BioNTech SE (NASDAQ:BNTX)Retireful LLC acquired a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,278 shares of the company's stock, valued at approximately $260,000. Other institutional investors alJanuary 17, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from AnalystsBioNTech SE (NASDAQ:BNTX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seventeen analysts that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, thirteen have assigned aJanuary 16, 2025 | marketbeat.comGoldman Sachs Sticks to Their Buy Rating for BioNTech SE (BNTX)January 15, 2025 | markets.businessinsider.comTruist Financial Issues a Buy Rating on BioNTech SE (BNTX)January 15, 2025 | markets.businessinsider.comBioNTech SE: BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | finanznachrichten.deBioNTech provides business and pipeline updatesJanuary 14, 2025 | markets.businessinsider.comBioNTech Unveils 2025 Strategic Priorities and Pipeline ProgressJanuary 14, 2025 | tipranks.comBioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | globenewswire.comTruist Securities Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Buy RecommendationJanuary 10, 2025 | msn.comTruist Securities Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Buy RecommendationJanuary 10, 2025 | msn.comBioNTech (NASDAQ:BNTX) Now Covered by Analysts at Truist FinancialTruist Financial began coverage on BioNTech in a research report on Friday. They set a "buy" rating and a $172.00 target price on the stock.January 10, 2025 | marketbeat.comPromising Oncology Pipeline and Financial Strength Drive BioNTech’s Growth ProspectsJanuary 10, 2025 | markets.businessinsider.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼1.400.60▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼511▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenx News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Viatris News Today Moderna News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
